COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1797.7 | 8 | 0206-0338 | 35.69 | 338.17 | 193 | 52.77 | 0.871 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 8803.9 | 8 | 0207-0338 | 283.63 | 337.80 | 194 | 52.28 | 0.892 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 6566.9 | 8 | 0208-0341 | 442.74 | 341.90 | 307 | 66.43 | 0.874 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1611.0 | 8 | 0209-0343 | 495.31 | 344.36 | 429 | 88.67 | 0.686 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 819.8 | 8 | 0210-0341 | 749.53 | 341.13 | 261 | 59.94 | 0.913 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 5890.3 | 8 | 0211-0342 | 409.14 | 342.94 | 258 | 59.70 | 0.910 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2962.5 | 8 | 0212-0344 | 786.04 | 343.56 | 228 | 55.94 | 0.916 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2182.3 | 8 | 0213-0343 | 223.49 | 343.69 | 205 | 53.11 | 0.913 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1411.9 | 8 | 0214-0345 | 72.07 | 344.02 | 253 | 60.77 | 0.861 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1029.9 | 8 | 0215-0347 | 615.45 | 347.13 | 290 | 64.53 | 0.875 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2658.6 | 8 | 0216-0349 | 847.39 | 348.96 | 278 | 64.08 | 0.851 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2520.0 | 8 | 0217-0349 | 162.16 | 349.02 | 209 | 53.94 | 0.903 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1430.3 | 8 | 0218-0352 | 904.73 | 351.46 | 230 | 59.11 | 0.827 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 4208.0 | 8 | 0219-0358 | 239.48 | 358.57 | 276 | 61.01 | 0.932 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3044.0 | 8 | 0220-0361 | 372.20 | 361.46 | 328 | 68.18 | 0.887 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2268.9 | 8 | 0221-0364 | 732.60 | 364.38 | 212 | 56.53 | 0.834 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 788.3 | 8 | 0222-0365 | 669.58 | 364.77 | 308 | 69.94 | 0.791 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 4245.5 | 8 | 0223-0363 | 542.40 | 363.96 | 167 | 48.63 | 0.887 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1335.7 | 8 | 0224-0367 | 825.59 | 367.27 | 264 | 63.01 | 0.836 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1235.6 | 8 | 0225-0368 | 69.91 | 368.36 | 423 | 77.60 | 0.883 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 4318.3 | 8 | 0226-0367 | 509.82 | 366.75 | 165 | 49.11 | 0.860 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2941.0 | 8 | 0227-0370 | 842.54 | 368.99 | 221 | 57.36 | 0.844 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3992.1 | 8 | 0228-0370 | 904.68 | 370.38 | 299 | 63.94 | 0.919 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1688.4 | 8 | 0229-0374 | 705.18 | 375.56 | 291 | 65.36 | 0.856 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 15858.1 | 8 | 0230-0380 | 229.26 | 379.63 | 336 | 69.01 | 0.887 |